2024 SPEAKERS
Patrick Caubel, Chief Safety Officer, Pfizer
Minyar Chelly Kahloun, Director, of QPPV-LSO & Medical Writing, ProductLife Group
Serban Ghiorghiu, Chief Safety Officer, AstraZeneca
Mariette M Boerstoel, Senior Vice President, Worldwide Patient Safety Officer, Bristol Myers Squibb
Martine Zimmermann, Senior Vice President, Head of Global Regulatory Affairs, Ipsen
Phil Tregunno, Deputy Director, Patient Safety Monitoring, Medicines & Healthcare products Regulatory Agency
Kathy Roberts, Vice President, Global Phamacovigilance, Incyte Corp.
Stewart Geary, Global Safety Officer, Eisai
Camilla Hammerum, Vice President, Head of GPS TA Oncology, Ipsen
Felix Arellano, Global Head of Pharmacovigilance and Drug Safety, Roche
Ercem Atillasoy, Chief Regulatory and Safety Officer, Jazz Pharmaceuticals
Rajakumari Long, Deputy Director, Integrated Development, Global Health, Bill and Melinda Gates Foundation
Karsten Lollike, Corporate Vice President, QPPV, Novo Nordisk
Shaloo Pandhi, Global Head, Patient Safety, Sandoz
Sarah Freestone, Vice President, Head of Pharmacovigilance and Device Safety, UCB PHARMA
Fabian Heisig, Senior Vice President, Head Global Drug Safety & QPPV, Grunenthal
Claudia Lehmann, Vice President, Head, Patient Safety & Pharmacovigilance Operations, Boehringer Ingelheim International
Meenal Patwardhan, Vice President, Medical Safety Evaluation & Safety Data Sciences, AbbVie
Fabio Lievano, Vice President, Safety Science, AbbVie
Deepa Venkataraman, Vice President, Head of Global Drug Safety and Pharmacovigilance, Corcept Therapeutics
Emma Outram, Group Head, Safety Data Acquisition, Roche Products Ltd
Peter Hjelmstrom, Director and Chief Executive Officer, Uppsala Monitoring Centre
Indy Ahluwalia, PV Consultant, Truliant Consulting
Vivek Ahuja, Senior Vice President, Compliance, EVERSANA
Adriana Aristizabal, Medical Director, Vitalis
Michael Braun-Boghos, Senior Director, Safety Strategy, Oracle Health Sciences
Jorge Carmona, Global Product Line Lead, Head, Patient Safety Risk Management Informatics, Roche
Mark Cawley, Associate Director, R&D Procurement, Jazz Pharmaceuticals
Amelie Fassbender, Regional Medical Director, Developed Markets, Viatris
Kevin Fetterman, Executive Director, Orbit, Orbit By Feith Systems
Lalit Gehani, Director, Analytics and Reporting, Ultragenic
Magdalena Gielo, Manager, PV Operations, Global Submissions, Moderna
Will Gordon, Senior Vice President, Product Management, Safety, ArisGlobal LLC
Lucy Green, Director, Local Safety and Pharmacovigilance, ProductLife Group
Martin Holm-Petersen, CEO, Insife
Nawal Jebbar, QPPV & Drug Safety Manager, TFS HealthScience
Elena Jimenez Gutierrez, Senior Business Consultant, NNIT A/S
Kanwalpreet Kaur, QPPV & Head of Strategic Development Group, APCER Life Sciences
Sam Kay, Vice President, Pharma, Basil Systems
Swadhin Khawas, Global Head of Solutions and Capabilities, HCLS, WNS Global Services Ltd
Narasimha Kumar, Chief Product and Commercial Officer, Datafoundry
Robert Kyle, Vice President, Product for Pharmacovigilance, Trinetx
Nikodem Latocha, Associate Director, Computerised Systems Quality, PrimeVigilance
Maulik Mehta, President, Safety and Pharmacovigilance, TriNetX
Martha Menzel, Director, Clinical Safety, Edwards Lifesciences
Raj More, Chief Architect & CEO, RxLogix Corporation
Roger Mutter, Medical Safety Director, Alfasigma Schweiz AG
Bruce Palsulich, Vice President, Safety, Oracle Life Sciences
Abdul Rahim, Founder Director, ALWIS Solutions Limited
Hans-Jörg Römming, Executive Director, Head of GPS Operations, Merck
Griselda Saldana, Director, Global Safety, Amgen
Sarah Sendrup, CCO & Principal Consultant, Herax
Jens-Ulrich Stegmann, Senior Vice President, Head Clinical Safety and Pharmacovigilance, EU QPPV, GSK
Ada Stelmakiene, Head of Pharmacovigilance, Insuvia
Sameer Thapar, Strategic Client Advisor, Oracle Health Sciences
Rupesh Thorat, Head, Drug Safety, SIRO Clinpharm Pvt Ltd
Koen Van der Heijden, Senior Director, EU & UK QPPV, Menarini Stemline
Sumit Verma, President, Clinical Safety and Pharmacovigilance Operations, Soterius, Inc.
Slobodan Vucinic, Senior Consultant, NNIT A/S
Robert Weber, Product Management Director, Oracle Health Sciences
Michał Zawistowski, Associate Director, Clinical Trial Safety Scientist, AstraZeneca
Mohamed Abdillahi, Director, Risk Management Product Lead, Pfizer
Esther Aparicio, Team Manager, Global Case Processing, UBC
Matt Aspinall, Head of Product & Engagement Manager, Axian Consulting ltd.
Swapnil Babasaheb Khot, Vice President & Delivery Leader Life, Sciences Digital Operations, Cognizant
Maja Barac, Chief Executive Officer & EU QPPV, Pharmavigil
Kate Bendall, Head of Implementation, Axian Consulting ltd.
Alex Brenchat, Vice President, Local Pharmacovigilance Services, PharmaLex
Jason Bryant, Vice President, Data & AI, ArisGlobal
Jay Dave, Technical Director, GPV & Risk Management, COD Research Pvt LTD
Francesca Dickins, Advisor, Medicines Quality Organization, Eli Lilly
Steve Dingman, Vice President, Independent PV Expert
Updesh Dosanjh, Practice Lead Safety Technology, IQVIA
Ekaterina Edle von Dall'Armi, Deputy Local QPPV & Senior Medical Advisor Patient Safety, GSK
Marie Flanagan, Director, Product Management, Safety Tech, IQVIA
Abhishek Garg, Delivery Director, Cognizant
Tanja Hoffman, Independent, Independent PV Expert
Myrto Ioannidi, Director, Global Case Processing, UBC
Maximilian Jacobs, Head of Vendor Management, Pharmacovigilance, Bayer AG
Rafael Josupeit, EEA QPPV, Procter & Gamble
Belkis Lanza, Drug Safety Coordinator, QBD Group
Dominika Łukasz, Associate Director, Clinical Trial Safety Scientist, AstraZeneca
Kausik Maiti, Executive Director, Safety Physicians, Parexel International
Sonia Mangnoesing, Director, Global Drug Safety, Arriello sro
Jose Miyar Olaiz, Senior Medical Director, Patient Safety Physician, AstraZeneca
Barry Mulchrone, Head of Safety Science & Strategy Lifecycle Safety, IQVIA
Ann-Marie Orange, Chief Information Officer and Global Head of R&D, ArisGlobal
Krupa Patel, Senior Safety Scientist, Global Patient Safety, Ipsen
Mark Perrott, Managing Partner, Axian Consulting ltd.
Jan Petracek, Chief Executive Officer, iVigee
Iveta Petrova, Director, Product Management, Digital Science
Donald Puccio, Senior Director, Team Leader/Business Process Owner Aggregate Reports, Pfizer
Jane Reed, Director, NLP, Applied AI Science, IQVIA
Nikesh Shah, Vice President and Global Head, Drug Safety and Pharmacovigilance, Indegene
Martin Sournac, Manager, Global Pharmacovigilance operations, Incyte
Louie Tan, Director, Medical Affairs, ClinChoice
Raj Vaghela, Chief Executive Officer, PubHive Ltd.
Valerie Vandevoorde, Executive Director, Global Pharmacovigilance Quality Head, Merck
Venkat Venkataramanan, PV Practice Lead, Life Science Operations, Cognizant
Sanjay Vyas, President, Safety & Logistics and Country Head, India, Parexel
Ajibade Adesina, Director, PV Process Excellence and Learning Strategy, Bristol-Myers Squibb
Nicole Baker, CEO, biologit
Marta Bałuka, Manager, Global Case Management, PV Operations, Moderna
Marianne Banoub, Regional Head of PV and QA, NewBridge Pharmaceutical
Tiago Barca Ramos, Global Lead, Clinical & Drug Safety, Compliance & Operations, Swiss QPPV, Bavarian Nordic
Matteo Barion, Digital Innovation & Technologies Unit Head, QPPV Office, Chiesi Farmaceutici SpA
Isabella Caramuta, Deputy QPPV, Shionogi BV
Fabrice Besle, Director, PV Database & Analytic Reporting, Ipsen
Mayank Bhandari, Co-Founder, Sales and Business Development, Ultragenic Research & Technologies LLC
Olga Błaszczyk, Manager, Global Case Management, PV Operations, Moderna
Mircea Ciuca, Executive Director, TA Lead, Global Pharmacovigilance, Organon
Galina Cordero, Head of Pharmacovigilance Department, QPPV, JSC Farmak
Magda Daudin, Director, Head of PV Operations and Compliance, Idorsia
Jolanda De Bruijne, Senior Director, Head of PV Compliance, Teva Pharmaceuticals
Dineke Eikelboom, Associate Director, Medical Safety, Pharmacovigilance, Astellas pharma
Veronica Fjellstrom, Global Head, Pharmacovigilance and Patient Safety, Oncopeptides AB
Joanna Han, Independent PV Expert
Pat Harding, Senior Advisor, Medicines Quality Organisation, Eli Lilly and Company
Nathalie Joffre, Global Vigilance Director, EU QPPV, Biocodex, Inc.
Anna Kończak, EU QPPV, Polpharma
Graeme Ladds, CEO & Owner, PharSafer
Ewa Malinowska, Associate Director, Global Pharmacovigilance Case Management, MSD
Paul Maruff, Chief Innovation Officer, Cogstate
Fabio Miceli, EU QPPV, Norgine
Raghunandan Murthy, Director, Business Transformation and PV Consulting, Sophos IT Services
Milind Nadgouda, Director, Operations, RiverArk Limited
Teodora Perger, Senior Medical Director, Global Safety Physician, AstraZeneca
Iwona Piotrowska-Potapczyk, Associate Director, Global Pharmacovigilance Case Management, MSD
Elena Prokofyeva, Head of Drug Safety Unit, DG Post, FAMHP - Federal Agency for Medicines and Health Products in Belgium
Humaira Qureshi, President, Qinecsa Solutions
Oana Rad, Senior Safety Scientist, B Braun
Tjark Reblin, Senior Vice President, Global Head of Patient Safety, Ipsen
Ranga Reddy, Head of Drug Safety Technologies, Former CSL Vifor
Nayanika Rivankar, Signal Management Strategy Lead, Merck Group
Balaji Sainath Malla, Head of Pharmacovigilance, QPPV- EU & UK, Dr. Reddy's Laboratories Inc
Teresa Saragoça, Technical Director and Head of Regulatory Affairs, Italfarmaco PT
Maurizio Sessa, Associate Professor, Pharmacovigilance and Pharmacoepidemiology, University of Copenhagen
Tim Stockley, Senior Director, Compliance and Inspection Readiness, Patient Safety, AstraZeneca
Azwi Takalani, Program Lead, HIV Vaccine Trials Network South Africa
Alina Ioana Tudor, Global Head, Medical Evaluation and ICSR Review, Kyowa Kirin
Martijn van de Leur, Chief Operating Officer PV/RA/MI, Biomapas
Sriram Venkateswaran, Safety Data Science Director, Hoffmann la Roche Ltd
Heinz Weidenthaler, Global Principal Safety Physician, EU QPPV, Bavarian Nordic
Mark Widdowson, Senior Manager, Digital Capabilities, WorldWide Patient Safety, Bristol Myers Squibb
Fatima Bhayat, Independent PV Expert
Celine Adessi, Global Head, Clinical Sciences, Early Development Oncology, Roche
Ana Sofia Afonso, Director, Pharmacoepidemiology, Global Patient Safety, Eli Lilly
Amit Aggarwal, Executive Director, Medical Affairs & Strategic Partnerships, ABPI
Omar Aimer, Executive Member of ISoP and NASoP President, International Society of Pharmacovigilance (ISoP)
Alison Allen, Director, Global Pharmacovigilance (PV) Quality Assurance, Alnylam Pharmaceuticals
Ibrahim Altamawy, Medical Affairs & Compliance Regional Head (MENA), SAJA Pharmaceuticals
Anand Ananthakrishnan, Senior Director, Drug Safety and Pharmacovigilance, Blueprint Medicines
Wasim Anwar, Vice President, Deputy QPPV, Novo Nordisk A/S
Julia Appelskog, Senior Director, EU QPPV, Global Vaccine Safety, Novavax
Mina G Awad, Pharmacovigilance Senior Manager and QPPV, Middle East, Kyowa Kirin International
Jamal Baig, Director, Pharmacovigilance, Multi Country Safety Head, Sanofi
Amina Baljic, Senior Director, Head, PV Operations and PV Excellence, Grunenthal
Alexandru Barbarosie, EU/UK QPPV, Global Safety Lead, Amryt Pharma
Judy Barretto, Senior Director, Virology TA, Patient Safety, Gilead
Eniko Barta Kondas, Head, Global PV Operations, Gedeon Richter PLC
Erica Bavol, Senior Director, Head of Safety Operations, Compliance and Systems, Corcept
Ricarda Berg, Head of Drug Safety Germany & Local QPPV, GSK
Majken Berghuis, Director, Pharmacovigilance, International Operations, Novo Nordisk
Kapil Bhutada, Director of Safety Operations and Compliance, Medical Safety & Pharmacovigilance, AskBio
Laura Paola Boga, Senior Director, Head of Global Pharmacovigilance, UK & EU QPPV, Dompé Farmaceutici SpA
Chris Bone, Director, Safety and Benefit Risk, Biogen
Emma Boulton, Director, Local Safety Operations, Mundipharma
Siva Kumar Buddha, Director, Pharmacovigilance, Head of Signals and Risk Management, Indegene Inc.
Akhilesh Chamediya, Global Medical Director, Patient Safety Lead, AstraZeneca & Alexion
David Chonzi, Independent Pharma Physician, Independent PV Expert
MUGDHA CHOPRA, Co-Founder and Director, AWINSA Life Sciences
Jan Cleerbout, Deputy QPPV, Johnson & Johnson Innovative Medicine
Marco Colombati, PV Operations Manager, ITALFARMACO S.P.A.
Lynne Comiskey, Divestment Coordination Lead, Sanofi
Mark Daniels, Director, Safety Physician, Jazz Pharmaceuticals
Abiola David, Senior Director, Global Process Owner, ICSR Management, PV Operations, GSK
Anthonius de Boer, Chairman, CBG-MEB Medicines Evaluation Board
Sunita Dhar, Executive Medical Group Director, Clinical Safety, Genentech
Daniela Di Cosmo, Senior Safety Advisor, Global Safety, Ferring Pharmaceuticals
Elisabetta Di Martino, Director, GCP, GVP & GLP, Quality Assurance, Orchard Therapeutics
Shaantanu Donde, Senior Medical Director, Head of Portfolio Management Team, Clinical Development & Medical Affairs, Viatris
Joan D'souza, Consultant, Independent PV Expert
Melanie Dullemond, PV Compliance Head, Medical and PV Quality, Sanofi
Phillip Eichorn, Global Head of Drug Safety, Chiesi
Sebastian Fischer, Regulatory Strategy Principal, TUV SUD Product Service GmbH
John Fitzpatrick, Senior Pharmacovigilance Manager, ProPharma
Ilana Frishman, Senior Director, Pharmacovigilance & Drug Safety, Compugen
Uwe Gudat, Chief Medical Officer, Biocon Biologics
Sibel Guerler, Senior Director, Head of Innovation, Partnerships and Process Optimisation, WorldWide Patient Safety, Bristol Myers Squibb
Israel Gutierrez, Chief Medical Officer, TLR Therapeutics
Diane Halle, Senior Manager, Pharmacovigilance Quality Assurance, Alnylam Pharmaceuticals
Conny Johansson, Alliance Management Lead, Roche
Justin Joubert, Senior Director, Acquisitions, PV Agreements & Contract Liason, GSK
Elena Keller, Director, PV, RA, Quality and Medical Operations, Local QPPV, Ipsen Pharma GmbH
Mohammed Ali Kotal, Global Head, Medical Safety, Sandoz International GmbH
Smruti Kothari, Associate Director, PV QA, Jazz Pharmaceuticals
Marcin Kruk, Senior Director, Drug Safety Unit Regional Head, Europe, Africa & Middle East, Pfizer
Luiz Lima, Vice President, Head of Neuroscience, Global Patient Safety, Ipsen
Emanuel Lohrmann, Director, PV Therapeutic Area Lead, Cardio Renal, Otsuka Pharmaceuticals
Claire Longman, Expert Pharmacovigilance Inspector, MHRA
Valentina Mancini, Senior Director, Pharmacovigilance, EU & UK QPPV, Shionogi & TransCelerate
Monika Manske, Associate Director, Lead Quality Management and Deputy EEA QPPV, Viatris
Marcin Marciniak, Senior Director, Global Safety and PV Expert WHC, Gedeon Richter Switzerland
Jessica Mårlind Würtele, Director, Patient Safety Excellence, AstraZeneca
Miriam Marotti, Senior Medical Director, Patient Safety Oncology, AstraZeneca
Jorgen Matz, Global Head, Pharmacovigilance & Clinical Quality, INSUD PHARMA
SANJEEV MIGLANI, Founder and Director, AWINSA Life Sciences
Andrew Moore, Director, PV Operations and Compliance, Takeda
Marianne Mounir, Senior Global System Auditor, Bayer
Céline Muffang, Associate Director, Medical Safety & Pharmacovigilance, AskBio
Sutirtha Mukhopadhyay, Senior Associate Director, Senior Patient Safety Physician, Boehringer Ingelheim
Dominic Nguyen-Van-Tam, Senior Pharmacovigilance Inspector, MHRA
Thomas Nirnberger, Chief Executive Officer, Biofi
Minhaj Obeidullah, Global Head Governance & Risk, Novartis
Tom Organ, Safety Science Director, Neuroscience TA, Global Patient Safety, Ipsen
George P. Patrinos, Professor, Department of Pharmacy & Adjunct Professor, Department of Genetics and Genomics, University of Patras & United Arab Emirates University
Anna Pelnikevich, Director, Head of Benefit-Risk Management, Merck
Emmanuelle Pinès, Head of Safety Policy & Process Oversight, QPPV Office, Janssen
Nathan Rivers, Associate Director, Medical Safety, Oncology, Jazz Pharmaceuticals
Zina Sadeq, Director, Regional PV and Alliance Management, Deputy UK QPPV, AMICUS THERAPEUTICS
Myriam Salem, National Good Pharmacovigilance Practices Inspection Program Coordinator, Health Canada
Yvonne Schäfer, Head of Patient Safety & Pharmacovigilance Systems Business Solutions, Boehringer Ingelheim International
Claudia Schaffer, Senior Director, Head of Case and Vendor Management, Merck
Olaf Schickling, Senior Director, Head of QPPV Office, BeiGene Germany GmbH
Nadine Schreiber, Head, Global Pharmacovigilance, medac GmbH
Uwe Schühly, Head of Drug Safety and Pharmacovigilance, Santhera Pharmaceuticals
Riti Shah, Senior Medical Director, Pharmacovigilance, Chiesi
John Solomon, Head of Pharmacovigilance, UK & Ireland, Sanofi
Anna Stahl, Deputy QPPV, BeiGene
Mette Stie Kallesøe, Head of Pharmacovigilance, QPPV, Hansa Biopharma
Johanna Strandell, Director, Patient Safety, Camurus AB
Karthick Sukumaran, Director, Technology Enablement, Intelligent Safety Automation, Roche Products Ltd
Jutta Syha, Independent PV Expert, Independent PV Expert
Stéphanie Tcherny-Lessenot, Global Head, Benefit-Risk Evaluation, Sanofi
Marco Tuccori, Pharmacovigilance Manager, Coordinator & Co-Chair, University Hospital of Pisa, Tuscan Regional Centre of Pharmacovigilance & ISoP Scientific Board
Lionel Van Holle, Founder, OpenSourcePV
Mary Lynne van Poelgeest-Pomfret, President, World Federation for Incontinence and Pelvic Problems (WFIPP)
Sarah Vaughan, Head of Vigilance Operations, MHRA
Michael von Forstner, Head of Safety Science, Global Pharmacovigilance and Patient Safety, Sobi (Swedish Orphan Biovitrum)
Ivana Vranic, Director, Safety Risk Lead, Inflammation & Immunology, Pfizer
Aman Wasan, Chief Executive Officer, ArisGlobal LLC
James Whitehead, Senior Director, Devices and Digital Safety, Astra Zeneca
Rui Yang, Senior Medical Safety Director, Team Lead, Pharmacovigilance, Drug Safety, Genmab
Dilara Yuksel Gunbay, Associate Director, Patient Safety, AHoPS, Gilead Sciences
Ludovic Apoux, Director, Safety Signal & Risk Management, Haleon
Tea Babic, Director, Head of PV Audits and Inspections, Deputy Head PV Compliance, Teva Pharmaceuticals
Erika Barbarosie, Associate Director, Compliance, Gilead Sciences
Begum Benli Peker, Director, Head of Patient Safety Netherlands & EU Hub Lead, Bristol Myers Squibb
Ronald Boumans, Independent Medical Devices Expert, EU Medical Devices Expert
Barbara Bovy, Director, Head, Auditing and Compliance EarlyDevSol, Innovation & Data, UCB
Sean Burke, Senior Director, Regional Lead, International Pharmacovigilance, MSD
Gloria Bustos, Senior Director, Global Head of Global Patient Safety, Renal Segment, Baxter Healthcare
Mattia Calissano, Director, Head of Pharmacovigilance, Orchard Therapeutics
Mijal Chavda, Senior Director, Global Head of GxP Inspections & GVP Quality, Kyowa Kirin International
Irina Maria Ciubotaru, Vice President, Head of Global Drug Safety and Pharmacovigilance, EU & UK QPPV, ITM Isotope Technologies Munich SE
Juan Daccach, Vice President, Global Product Safety, Merz Aesthetics
Margherita D'Antuono, EU-UK QPPV, Piramal Critical Care
Michelle Dardeno, Vice President, Aurinia
Fabio De Gregorio, Vice President, Head Of Drug Safety Europe, Shionogi BV
Frédérique Delannois, Executive Director, Safety Evaluation & Risk Management Head, Global Safety, GSK
Attila Oláh, Vice President, Head, Global Patient Safety, EU-QPPV, Gedeon Richter PLC
James Eldridge, Director, Global Safety Surveillance, Y-mAbs
Antonella Fretta, Senior Director, Aggregate Reporting Team Lead, Pfizer
Tsambika Fuchs, Team Lead PV Intelligence and Performance Management, Merck Healthcare KGaA
Giovanni Furlan, Director, Worldwide Safety Site Lead, Pfizer
Ilaria Grisoni, Executive Director, Head of EU & International Pharmacovigilance, QPPV Office and EEA QPPV, Jazz Pharmaceuticals
Katarzyna Gruchala, Director, PV Operations Global Submissions, Moderna
Cristina Hentea, Director, Safety Surveillance and Risk Management, Viatris
Juri Hodisch, Head, Drug Safety, QPPV, AOP Health
Philip Jones, Senior Director, Disease Area Cluster Lead, Inflammation & Immunology, Pfizer
Achilleas Kalogirou, Lead, Office of Safety Operations, AbbVie
Elena Cucu, Deputy EU QPPV, AbbVie
Ranjana Khanna, Global Director, GVP, QA, R&D Quality, BeiGene
Ben Kitchens, Associate Director, Medical Devices, Diagnostics Lead, Otsuka Pharmaceutical Companies (U.S.)
Kristin Knalstad, Director, Risk Management, Patient Safety, AstraZeneca
Peter Kohut, Head of Pharmacovigilance, Alvotech
Monika Kowalska, Director, Global Case Management, Moderna
Leith Kwaan, QPPV, National Bioproducts Institute NPC
Jost Leemhuis, Safety Science Partner and Global Business Lead, Roche
Rita Lobatto, Vice President, Pharmacovigilance & QPPV, Pharming Group
Asif Mahmood, Vice President, Medical Safety & Pharmacovigilance, AskBio
Asa Mattsson, Senior Director, Patient Safety Risk Management, Process & Implementation, AstraZeneca
Richard Mayer, Senior Principal Engineer, Head of Medical Safety R&D, Johnson and Johnson
Kieran O'Donnell, Director, Independent PV Expert
Adeniyi Olagunju, Senior Lecturer, University of Liverpool
Karine Palin, Eu2P Programme Manager, University of Bordeaux
Nibedita Rath, Scientific Director, Open Source Pharma Foundation
Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI
Hadir Rostom, Independent PV Expert - Lecturer, Modern Sciences And Arts University
Kishore Saha, Chief Specialist, Lundbeck
Gemma Sayers, Senior Director, Head, Global Development Quality Management, Regeneron Pharmaceuticals
Rudi Scheerlinck, Safety Strategy Lead, Merck Healthcare Oncology
Reinhold Schilling, Head of Global Pharmacovigilance, EU QPPV, Wörwag Pharma
Carrie Scott, Head, Global Pharmacovigilance Compliance and Policy, AbbVie
Vivien Stettner, Director, International PSEQ Strategy & Sights, AbbVie
Milos Stojkovic, Safety Process Director, Roche
Ariane Stollenwerk, Director, Head of Central Europe & Asian Int. Markets, International PhV, UCB PHARMA
Tarak Thakker, Director, Safety Systems and Reporting, BeiGene
Rebecca Webb, Senior Director, Safety, Vigilance and Medical Affairs QA, AbbVie
Monika Zych, Director, Pharmacovigilance, Baxter
Marjan Dzeparoski, RA and PV Manager, Bionika Pharmaceuticals
Maha Lakshmi Elluri, Global Safety Director, EEA/UK QPPV, Indivior Pharmaceuticals
Suzanne Foncin, Senior Director, Head of Safety Analysis and Writing, UCB
Yvonne Nanciu, Country Head, Pharmacovigilance, Deputy EU QPPV, Bayer
Claudia Pierleoni-Nielsen, Director, Global Safety Surveillance, LEO Pharma
Bert Van Leeuwen, Senior Director, Deputy QPPV, Astellas Pharma Europe BV
Heike von Treichel, Senior Director, Deputy EU QPPV, Head of PV QMS and QPPV Office, Merck
Get Involved At
World Drug Safety Congress
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events